Hugel

휴젤 · 145020

Health Care Pharmaceuticals · KOSDAQ

Large-cap

Market cap US$2.2B (₩3T)

Overview

Company summary coming soon.

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$308.1M

▲ +14.0% YoY

Operating profit · FY2025

US$145.5M

▲ +20.8% YoY

Net income · FY2025

US$106.5M

▲ +2.7% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$231.7M(₩319.7B)	US$270.3M(₩373B)	US$308.1M(₩425.1B)
Operating profit	US$85.3M(₩117.8B)	US$120.5M(₩166.2B)	US$145.5M(₩200.9B)
Net income	US$70.8M(₩97.7B)	US$103.7M(₩143.1B)	US$106.5M(₩147B)

Revenue

Operating profit

Net income

ROE

15.0%

Debt/Eq

9.9%

Op. margin

47.3%

Net margin

34.6%

Rev. YoY

▲ +14.0%

Interactive price history isn't here yet. Would you use it?